CN Patent

CN101330907A — 含普瑞巴林、基质形成剂和溶胀剂并适于每日口服一次的固体药物组合物

Assigned to Viatris Specialty LLC · Expires 2008-12-24 · 17y expired

What this patent protects

本发明描述了一种含普瑞巴林的固体药物组合物。该组成物包括基质形成剂和溶胀剂，并适于每日口服一次。基质形成剂的实例包括聚醋酸乙烯酯和聚乙烯基吡咯烷酮的混合物，而溶胀剂的实例包括聚乙烯基吡咯烷酮的交联聚合物。

USPTO Abstract

本发明描述了一种含普瑞巴林的固体药物组合物。该组成物包括基质形成剂和溶胀剂，并适于每日口服一次。基质形成剂的实例包括聚醋酸乙烯酯和聚乙烯基吡咯烷酮的混合物，而溶胀剂的实例包括聚乙烯基吡咯烷酮的交联聚合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN101330907A
Jurisdiction
CN
Classification
—
Expires
2008-12-24
Drug substance claim
No
Drug product claim
No
Assignee
Viatris Specialty LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.